— Sports

Mississippi health officer: Refrain from J&J vaccine for now

JACKSON, Miss. (AP) – Mississippi’s top public health official said Tuesday that he’s telling health care providers to refrain from using the Johnson & Johnson COVID-19 vaccine. At the same time, federal agencies investigate reports of potentially dangerous blood clots.

Dr. Thomas Dobbs said health care providers should wait for “additional guidance” from the Centers for Disease Control and Prevention and the Food and Drug Administration.

Dobbs also wrote on Twitter: “Those who have received JnJ already should not be worried.”

The CDC and the FDA said Tuesday they were investigating unusual clots that occurred 6 to 13 days after vaccination. The clots occur in veins that drain blood from the brain and appear together with low platelets. All six cases were in women between 18 and 48; there was one death, and all remained under investigation. The reports appear similar to a rare, unusual type of clotting disorder that European authorities say is possibly linked to another COVID-19 vaccine not yet cleared in the U.S., from AstraZeneca.

More than 6.8 million doses of the J&J; vaccine have been administered in the U.S., the vast majority with no or mild side effects. Dobbs said records show 38,885 doses of the Johnson & Johnson vaccination have been given in Mississippi. That is about 2.7% of the 1,456,187 doses of COVID-19 vaccine given in the state.

Follow AP’s coverage of the pandemic at https://apnews.com/hub/coronavirus-pandemic and https://apnews.com/UnderstandingtheOutbreak.

Sign up for Daily Newsletters

Copyright © 2021 The Washington Times, LLC

Molly Aronson

Molly Aronson is a 26-year-old government politician who enjoys bowling, running and jigsaw puzzles. She is creative and exciting, but can also be very greedy and a bit greedy.She is an australian Christian who defines herself as straight. She has a post-graduate degree in philosophy, politics and economics. She is allergic to grasshoppers.

Related Articles

Leave a Reply

Your email address will not be published.

Back to top button